Seres Therapeutics Inc Cash Flow Reinvestment Rate
Seres Therapeutics Inc cash flow reinvestment rate. Seres Therapeutics Inc (MCRB) has a Cash Flow Reinvestment Rate of 0.01x as of September 2025, reinvesting $16.00K (capex $8.00K plus investments $-8.00K) from operating cash flow of $2.21 Million. Explore MCRB operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Seres Therapeutics Inc (2016–2025)
Cash flow reinvestment rate of Seres Therapeutics Inc from 2016 to 2025. Historical reinvestment intensity for Seres Therapeutics Inc across 3 annual periods. Explore Seres Therapeutics Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Seres Therapeutics Inc Cash Flow Reinvestment Rate by Year (2016–2025)
Seres Therapeutics Inc cash flow reinvestment rate by year from 2016 to 2025. Year-by-year capital reinvestment analysis for Seres Therapeutics Inc. For the full cash flow conversion analysis, see MCRB cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.23x | $252.00K | $1.12 Million | $252.00K | ▼ -98.2% |
| 2021 | 12.44x | $83.22 Million | $6.69 Million | $9.57 Million | ▲ +733.2% |
| 2016 | 1.49x | $65.59 Million | $43.92 Million | $21.49 Million | — |